A. Vakrakou

发表

Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren's syndrome fueled by inflammagenic DNA accumulations.

P. Ziakas, A. Vakrakou, S. Boiu, 2018, Journal of autoimmunity.

Cell-autonomous epithelial activation of AIM2 (absent in melanoma-2) inflammasome by cytoplasmic DNA accumulations in primary Sjögren's syndrome.

V. Gorgoulis, K. Evangelou, A. Vakrakou, 2020, Journal of autoimmunity.

Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.

A. Papadopoulou, H. Moutsopoulos, A. Vakrakou, 2015, Journal of autoimmunity.

Impaired Clearance of Early Apoptotic Cells Mediated by Inhibitory IgG Antibodies in Patients with Primary Sjögren's Syndrome

H. Moutsopoulos, A. Vakrakou, M. Manoussakis, 2014, PloS one.

Decreased serum DNase1-activity in patients with autoimmune liver diseases

A. Vakrakou, M. Manoussakis, G. Dalekos, 2017, Autoimmunity.

The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data

M. Anagnostouli, A. Alexaki, L. Stefanis, 2022, International journal of molecular sciences.

Impaired anti-inflammatory activity of PPARγ in the salivary epithelia of Sjögren's syndrome patients imposed by intrinsic NF-κB activation.

D. Thanos, E. Kapsogeorgou, A. Vakrakou, 2018, Journal of autoimmunity.

M. Anagnostouli, G. Koutsis, S. Theocharis, 2021, Journal of Neuroimmunology.

HLA-genotyping by next-generation-sequencing reveals shared and unique HLA alleles in two patients with coexisting neuromyelitis optica spectrum disorder and thymectomized myasthenia gravis: Immunological implications for mutual aetiopathogenesis?

M. Anagnostouli, G. Koutsis, L. Stefanis, 2022, Multiple sclerosis and related disorders.

Peripheral blood natural killer cells in sarcoidosis are associated with early cardiac involvement

G. Stratakos, N. Kelekis, E. Gialafos, 2022, European journal of clinical investigation.

Neuronal and Neuroaxonal Damage Cerebrospinal Fluid Biomarkers in Autoimmune Encephalitis Associated or Not with the Presence of Tumor

E. Kapaki, G. Paraskevas, A. Vakrakou, 2022, Biomedicines.

Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases

E. Kapaki, A. Vakrakou, F. Boufidou, 2022, Diagnostics.

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases

L. Stefanis, A. Vakrakou, C. Kilidireas, 2022, Frontiers in Neurology.

Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review

M. Anagnostouli, G. Koutsis, L. Stefanis, 2020, Rheumatology International.

Co-occurrence between hereditary angioedema and multiple sclerosis: Therapeutic management of both diseases with fingolimod

M. Anagnostouli, G. Koutsis, L. Stefanis, 2022, Clinical Neurology and Neurosurgery.

Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients

M. Anagnostouli, G. Koutsis, A. Vakrakou, 2021, Clinical and experimental medicine.

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature

M. Anagnostouli, G. Koutsis, L. Stefanis, 2020, Frontiers in Neurology.

Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis

L. Stefanis, A. Vakrakou, J. Tzartos, 2022, Therapeutic advances in neurological disorders.

A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes

M. Anagnostouli, G. Koutsis, L. Stefanis, 2018, BMC Neurology.

Myasthenia gravis, atypical polyneuropathy and multiple autoimmune phenomena in the same patient, with HLA-immunogenetic profile expectable for Greek chronic inflammatory demyelinating polyneuropathy: a case report

C. Nikolaou, M. Anagnostouli, N. Karandreas, 2020, The International journal of neuroscience.

Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases

M. Anagnostouli, G. Koutsis, L. Stefanis, 2021, Therapeutic advances in neurological disorders.

An Updated Evaluation of Intrathecal IgG Synthesis Markers in Relation to Oligoclonal Bands

M. Anagnostouli, L. Stefanis, A. Vakrakou, 2023, Diagnostics.

Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis

L. Stefanis, G. Velonakis, A. Vakrakou, 2023, Frontiers in Immunology.

Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study

M. Anagnostouli, G. Koutsis, L. Stefanis, 2021, Multiple sclerosis.

Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts

M. Anagnostouli, G. Koutsis, E. Dardiotis, 2020, BMC Neurology.

Paraneoplastic basal ganglia encephalitis associated with anti-CV2/CRMP-5 and anti-Yo antibodies in a patient with non-small-cell lung cancer

L. Stefanis, G. Velonakis, E. Kapaki, 2020, Neurological Sciences.

Area postrema involvement in chronic lymphocytic inflammation with pontine perivascular enhancement

L. Stefanis, E. Kapaki, G. Paraskevas, 2020, Neurological Sciences.

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease

Maria Papadopoulou, G. Tsivgoulis, S. Tzartos, 2023, Frontiers in immunology.

Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review

A. Vakrakou, K. Yiannopoulou, J. Tzartos, 2023, Diagnostics.